In this video, shared by Continence Foundation of Australia, listen to Specialist Continence & Women’s Health Physiotherapist, Shan Morrison, as she discusses urinary incontinence in men after prostate cancer surgery. Dr. Morrison also talks about pelvic floor exercises and how these can help men in their recovery. Watch the video here.
Prostate Cancer Surgery and Pelvic Floor Exercises: What to Know Read More »
Robot-assisted and open radical surgeries for prostate cancer have similar outcomes for patients at 3 months, according to clinical trial results published in the Lancet. Read the first article here.
After 16 years, robotic surgery for prostate cancer still is debated Read More »
Many men who are told their surgery for prostate cancer has been a success later discover that this is not the case. The level of a protein in their blood, called prostate specific antigen, PSA, begins to rise signalling they still have prostate cells in their body even though they were told the entire prostate had been removed. There has been long standing debate about how best to predict who will fail after surgery. The current debate focuses on the value of pathologists examining the excised prostate and trying to detect, under the microscope, whether tumour cells have invaded the
Predicting if your surgery for prostate cancer will fail Read More »
September 2016 Awareness Night A Surgeon and His Patient – A Patient and His Surgeon Mark Cullen, Gardening Expert Radio and Television Personality and Best-selling Author Well-known newspaper and magazine columnist Member of the Order of Canada Prostate Cancer Survivor DR. GROLL’S PATIENT Dr. Ryan Groll, MD, MSc, FRCPC Endourologist, Laparoscopic and Robotic Surgeon Michael Garron Hospital (Toronto East Health Network) (formerly Toronto East York General Hospital) Lectuter, Dept. of Surgery, U. of Toronto MARK CULLEN’S SURGEON CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 52:22 minutes
Video: A Surgeon and His Patient Read More »
This New England Journal of Medicine article gives the results of a randomized trial of 3 possible prostate cancer treatments. It is rather long and academic, but shows similar results for the 3 options. Read the article here.
Studies have shown that radical prostatectomy can improve progression-free and overall survival in patients with lymph node-positive prostate cancer. While this finding requires further validation, it does allow urologists to question the former treatment paradigm of aborting surgery when lymph node invasion from prostate cancer occurred, especially in patients with limited lymph node tumor infiltration. Studies show that intermediate- and high-risk patients should undergo extended pelvic lymph node dissection up to the common iliac arteries in order to improve nodal staging. Read the article.
Extended lymph node dissection in robotic radical prostatectomy Read More »
The loss of erectile function after surgery Radical Prostatectomy is most frequently caused by intraoperative injury to the neurovascular bundles. It is known that if both bundles are removed, patients seldom recover erectile function. Accordingly, neurovascular bundle preservation during Radical prostatectomy has proven benefits in terms of erectile function recovery. Read the article.
Erectile Function Recovery after Radical Prostatectomy in Men with High-Risk Features Read More »
Technology developed in Oxford to make tumour cells fluorescent could improve surgery outcomes for men with prostate cancer. Fluorescent compounds show up diseased cells during keyhole operations, allowing surgeons to be more precise when removing the prostate and tissue around it. Read the article.
Pioneering Oxford surgery technique could improve treatment for prostate cancer Read More »
A survey showed men who underwent radical prostatectomy, especially robotic radical prostatectomy, had unrealistic expectations about how well they would function sexually postoperatively. Read the article.
Men Unclear on Sexual Function After Prostatectomy Read More »
The optimal treatment of clinically localized prostate cancer is controversial. Most studies focus on biochemical (PSA) failure when comparing radical prostatectomy (RP) with radiation therapy (RT), but this endpoint has not been validated as predictive of overall survival (OS) or cause-specific survival (CSS) The available literature was analyzed to determine whether reliable conclusions could be made concerning the effectiveness of RP compared with RT with or without androgen deprivation therapy (ADT). Reliable evidence that RP provides a superior CSS to RT with ADT is lacking. The most reliable studies suggest that the differences in 10-year CSS between RP and RT